Antiphospholipid syndrome (APS) is an autoimmune disease and is a risk factor for a
number of clinical manifestations; the classic presentations include fetal death or thrombosis …

Several antiphospholipid antibody (aPL) profiles (“triple” and lupus anticoagulant [LA]
positivity) are associated with a higher risk for clinical manifestations of antiphospholipid …

The diagnosis of antiphospholipid syndrome (APS) requires the presence of both clinical
and biological features. Due to the heterogeneity of anti-phospholipid antibodies (aPL) the …

Summary Immunoglobulin (Ig) G/IgM autoantibodies to phosphatidylserine/prothrombin
(aPS/PT) were evaluated individually and in combination with criteria anti-phospholipid …

SUMMARY Background: Antibodies Anticardiolipin (aCL) and anti-β2-glycoprotein I
(aβ2GPI) are two of three laboratory criteria of antiphospholipid syndrome (APS). All of …

Antiphospholipid (aPL) syndrome (APS) is an autoimmune disorder characterized by
thrombosis and/or certain pregnancy-related complications in association with persistence …

Despite the efforts made in the past to standardize Antiphospholipid (aPL) ELISA and the
high rate of concordance reached at that time, lJ in the following years different reports have …

The diagnosis of seronegative antiphospholipid syndrome (APS) has been proposed for
patients with well-defined clinical APS but persistently negative for the routinely tested …

Lupus anticoagulant (LA) and anticardiolipin (aCL) antibodies are the classical tests used to
diagnose the antiphospholipid syndrome (APS). Unfortunately, since these are nonspecific …

Objectives Anti-β2 glycoprotein I domain I (anti-domain I) and anti-phosphatidylserine/
prothrombin (aPS/PT) antibodies are present in patients with antiphospholipid syndrome …